Skip to main navigation
Skip to Content
Terns Pharmaceuticals
  • About Us
    • Leadership
    • Board of Directors
  • Our Approach
    • Our Approach
    • Scientific Publications
  • Pipeline
    • Pipeline
    • Our Programs
    • Expanded Access
  • Investors & Media
    • Overview
    • Press Releases
    • Events and Presentations
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Email Alerts
  • Partnerships
  • Careers

Press Releases

02.2.23
Terns Pharmaceuticals to Participate in Guggenheim Healthcare Talks 2023 Oncology Conference
01.12.23
Terns Pharmaceuticals to Present at B. Riley Securities’ 3rd Annual Oncology Conference
01.5.23
Terns Pharmaceuticals to Highlight 2023 Priorities and Clinical Milestones at the 41st Annual J.P. Morgan Healthcare Conference

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Current page 3
Email Alerts
RSS Feeds
Print Page
Contact IR
Terns Logo
TERNS
1065 East Hillsdale Blvd., Suite 100
Foster City, CA 94404 (MAP)
info@ternspharma.com
investors@ternspharma.com
media@ternspharma.com
Phone: +1 650-525-5535 Ext.101
Fax: +1 650-275-4254
  • LinkedIn
  • Twitter
  • About Us
  • Our Approach
  • Pipeline
  • Investors & Media
  • Partnerships
  • Careers
  • Contact Us
© 2023 Terns Pharmaceuticals, Inc. Privacy Policy